Sharda Medical Nursing Home And Eye Care Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 25-07-2024
- Paid Up Capital ₹ 2.10 M
as on 25-07-2024
- Company Age 19 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 21.94%
(FY 2023)
- Profit 27.44%
(FY 2023)
- Ebitda 25.49%
(FY 2023)
- Net Worth 16.22%
(FY 2023)
- Total Assets 13.71%
(FY 2023)
About Sharda Medical Nursing Home And Eye Care
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jayesh Shah, Ritaben Shah, Aalap Shah, and One other member serve as directors at the Company.
- CIN/LLPIN
U85110GJ2005PTC046960
- Company No.
046960
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Oct 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Gandhinagar, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sharda Medical Nursing Home And Eye Care?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayesh Shah  | Director | 21-Oct-2005 | Current |
| Ritaben Shah | Director | 21-Oct-2005 | Current |
| Aalap Shah | Additional Director | 29-Dec-2016 | Current |
| Jainam Shah | Director | 15-Jun-2023 | Current |
Financial Performance of Sharda Medical Nursing Home And Eye Care.
Sharda Medical Nursing Home And Eye Care Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 21.94% increase. The company also saw a substantial improvement in profitability, with a 27.44% increase in profit. The company's net worth Soared by an impressive increase of 16.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sharda Medical Nursing Home And Eye Care?
In 2023, Sharda Medical Nursing Home And Eye Care had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sharda Multispeciality Medicare Hospital Private LimitedActive 1 year 1 monthJayesh Shah, Ritaben Shah and 2 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sharda Medical Nursing Home And Eye Care?
Unlock and access historical data on people associated with Sharda Medical Nursing Home And Eye Care, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sharda Medical Nursing Home And Eye Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sharda Medical Nursing Home And Eye Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
